Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer

News   May 23, 2013

 
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
 
 
 

RELATED ARTICLES

Overexpression of a Cell-cycle Activator Gene Enhances Repair of Dead Heart Muscle

News

Biomedical engineers report a significant advance in efforts to repair a damaged heart after a heart attack, using grafted heart-muscle cells to create a repair patch.

READ MORE

Genomics Researchers Showcase their Applications of Droplet Digital PCR at ASHG 2017 Annual Meeting

News

The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the American Society of Human Genetics (ASHG) 2017 Annual Meeting.

READ MORE


 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE